People with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) should not take it
However, another study by Cantini et al., used GLP-1(7-36), GLP-1(9-36) and Liraglutide to induce apoptosis in unstressed hASC, as assessed in annexin-V expression on the surface, though only the effect of Liraglutide and GLP-1(7-36) was partially reversed by the GLP-1-R-Antagonist Exendin(9-36), supporting receptor-specific activity [12]
With the stakes so high, companies are chasing these outcomes in the billion dollar GLP-1 market, trying to figure out whether their genetic models can determine which GLP-1 someone should take, predict how much weight they might lose, whether they experience side effects and what happens after treatment stops
Prednisone helps manage symptoms such as swelling, redness, and pain
Then, COVID hit
We start with your health and labs, not with a default medication